Pacira | PCRX - PE Price to Earnings

Stock Price
23.13
Daily Change
-0.33 -1.41%
Monthly
16.52%
Yearly
-8.87%
Q1 Forecast
22.50

Pacira reported $29.24 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
Astellas Pharma JPY 7.31 2.04 Dec/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Cara Therapeutics 27.77 117.09 Sep/2021
Ironwood Pharmaceuticals USD 204.24 88.19 Dec/2024
J&J USD 23.62 0.86 Dec/2025
Ligand Pharmaceuticals USD 60.65 17.62 Sep/2025
Novo Nordisk DKK 12.78 0.01 Dec/2025
Pacira USD 29.24 6.15 Sep/2025
Perrigo USD 34.31 15.46 Sep/2025
Pfizer USD 14.48 5.18 Dec/2025
Supernus Pharmaceuticals USD 110.38 71.27 Dec/2025
Teva Pharmaceutical Industries USD 10.11 1.04 Dec/2025
Xoma 52.12 3.09 Sep/2022
Zoetis USD 20.42 2.84 Dec/2025